The Role of tetrahydrobiopterin and dihydrobiopterin in ischemia/reperfusion injury when given at reperfusion

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Reduced nitric oxide (NO) bioavailability and increased oxidative stress are major factors mediating ischemia/reperfusion (I/R) injury. Tetrahydrobiopterin (BH 4) is an essential cofactor of endothelial NO synthase (eNOS) to produce NO, whereas dihydrobiopterin (BH 2) can shift the eNOS product profile from NO to superoxide, which is further converted to hydrogen peroxide (H 2 O 2) and cause I/R injury. The effects of BH 4 and BH 2 on oxidative stress and postreperfused cardiac functions were examined in ex vivo myocardial and in vivo femoral I (20min)/R (45min) models. In femoral I/R, BH 4 increased NO and decreased H 2 O 2 releases relative to saline control, and these effects correlated with improved postreperfused cardiac function. By contrast, BH 2 decreased NO release relative to the saline control, but increased H 2 O 2 release similar to the saline control, and these effects correlated with compromised postreperfused cardiac function. In conclusion, these results suggest that promoting eNOS coupling to produce NO and decrease H 2 O 2 may be a key mechanism to restore postreperfused organ function during early reperfusion. Copyright © 2010 Qian Chen et al.

Cite

CITATION STYLE

APA

Young, L. H., Chen, Q., Kim, E. E. J., Elio, K., Zambrano, C., Krass, S., … Adams, J. S. (2010). The Role of tetrahydrobiopterin and dihydrobiopterin in ischemia/reperfusion injury when given at reperfusion. Advances in Pharmacological Sciences, 2010. https://doi.org/10.1155/2010/963914

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free